Gulf International Bank (Uk) LTD Sarepta Therapeutics, Inc. Transaction History

Gulf International Bank (Uk) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $250,686 - $351,424	-3,800 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$69.38 - $86.75 $983,461 - $1.23 Million	-14,175 Reduced 78.86%	3,800 $140,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $21,675 - $50,685	-300 Reduced 1.64%	17,975 $1.34 Million
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $313,900 - $446,850	-2,500 Reduced 12.03%	18,275 $3.12 Million
Q3 2020 Oct 21, 2020	SELL	$127.12 - $172.34 $22,246 - $30,159	-175 Reduced 0.84%	20,775 $2.92 Million
Q3 2019 Oct 08, 2019	BUY	$72.81 - $156.91 $1.53 Million - $3.29 Million	20,950 New	20,950 $1.58 Million

528

83.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.